In a research report released today, MLV’s healthcare analyst Vernon Bernardino reiterated a Buy rating on shares of Pluristem Therapeutics Inc (NASDAQ:PSTI), with a $6 …
In a research report released today, MLV analyst Arlinda Lee maintained a Buy rating on shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI), and reduced the …
MLV analyst Vernon Bernardino reiterated a Buy rating on shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) with a $1.
Analysts are weighing in today on Galena Biopharma Inc (NASDAQ:GALE) with mixed ratings, as the company released its second-quarter earnings results after the …
MLV’s healthcare analyst Thomas Yip weighed in with a few insights on Geron Corporation (NASDAQ:GERN), following the company’s second-quarter results and update on its clinical …
MLV analyst Arlinda Lee weighed in with a few insights on Synta Pharmaceuticals Corp. (NASDAQ:SNTA), after the company released its second-quarter results and provided update on its pipeline.
In a research report released Tuesday, MLV analyst Thomas Yip reiterated a Buy rating on shares of OXiGENE Inc (NASDAQ:OXGN) with a price target …
Keryx Biopharmaceuticals (NASDAQ:KERX) reported second-quarter financial results yesterday and provided an update on its ongoing US launch of its dialysis drug, Auryxia. The Boston-based …
In a research report issued today, MLV analyst Vernon Bernardino reiterated a Hold rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with a price target of …
MLV analyst Raghuram Selvaraju came out with a research report today on Neuralstem, Inc. (NYSE MKT:CUR) in anticipation of several upcoming clinical catalysts for …
